The mRNA is protected by a lipid coating, like a fat bubble. The mRNA enters healthy cells through a process developed by Moderna. Once inside, the cell produces spike proteins similar to those on ...

which centers on the technology used in Moderna’s COVID-19 vaccine, MRNA-1273. At the heart of the dispute are six U.S.

BioNTech has signed two new deals with manufacturers to produce lipids at scale, while Moderna's supplier told Reuters it has recently doubled its monthly production of the key ingredients.